---
title: "A Robot That Works Overnight in Pharmacies Just Raised ¥2.5 Billion"
date: 2026-11-22
category: Humanoids & Robotics
site: NeuroAI
canonical: https://neuroai.site/a/na-robot-galbot-pharmacy-funding
language: en
---

# A Robot That Works Overnight in Pharmacies Just Raised ¥2.5 Billion

> Galbot's funding shows how embodied intelligence is being sold into pharmacies and battery plants, where a robot must work unattended.

A pharmacy at midnight has no pharmacist behind the counter. A robot moves along the shelves, picks a package, and places it in a collection slot. The customer never sees a human being. This is not a demonstration staged for cameras; it is a business model that only works if the machine is reliable for hours without supervision.

Galbot (银河通用), a Beijing robotics company, has built its case on such unglamorous tasks. In March 2026 it announced a new financing round of ¥2.5 billion (≈ US$350M), according to People's Daily and other Chinese outlets. The company is led by Wang He (王鹤), a researcher at Peking University who founded an academic laboratory in embodied intelligence (具身智能) before turning to products.

## Key takeaways

- Galbot raised ¥2.5 billion (≈ US$350M) in a round announced in March 2026.

- Its robots operate in smart pharmacies across 24 cities, managing more than 5,000 stock-keeping units per store.

- An industrial model, Galbot S1, has a dual-arm maximum payload of 50 kg and is used in a CATL battery factory.

- The company's G1 humanoid performed tasks autonomously on the 2026 CCTV Spring Festival Gala.

- Investors include state-backed funds; reported valuations come from company and local-government sources, not a public filing.

## The 10-things-well strategy

Wang He has described the strategy as aiming for ten things done to industrial standards rather than a hundred done superficially — a formulation the company uses in its own materials. That sentence explains the product line better than any specification sheet.

The retail product is a wheeled humanoid that works in what the company calls an instant-retail warehouse and smart pharmacy. According to People's Daily, this operation has run continuously around the clock for more than a year in 24 cities, with each site managing over 5,000 distinct products. A related format, the "Galaxy Capsule" convenience store, has been installed in more than 100 locations across over 20 cities.

These numbers matter because a robot in a public retail space cannot be remotely operated by a hidden technician at scale. It must recognise arbitrary products, handle unfamiliar packaging, and recover from errors. A pharmacy is also a demanding environment: small objects, similar-looking boxes, and real consequences for mistakes.

The industrial product is different. Galbot S1, which had launched in January 2026, is a heavy-duty humanoid with a reported dual-arm maximum load of 50 kilograms, designed to work in dust, vibration, and temperature variation. The company says it operates autonomously in a CATL battery factory and can swap its own batteries. Other named customers include Bosch, Toyota, BAIC, and SAIC, with cumulative orders described as being in the thousands of units.

## Why the Spring Festival Gala mattered

In the 2026 CCTV Spring Festival Gala, a Galbot G1 appeared alongside comedians and performed tasks including cracking walnuts, picking up glass fragments, taking items from a shelf, folding clothes, and threading sausages. The company says the actions were decided in real time by its embodied model rather than executed as a fixed programme.

Television exposure is not technical evidence, but in the Chinese robotics market it has a practical function. It creates name recognition for industrial buyers and reassures local governments considering pilot projects. A robot that can handle a chaotic stage, with changing lights and unscripted interaction, is at least a credible starting point for a warehouse.

## Reading the funding

The March round drew strategic and state-backed investors, including the National Artificial Intelligence Industry Investment Fund and Sinopec, according to local government reporting. Hangzhou authorities later described the company's valuation as exceeding ¥20 billion (≈ US$2.8B). Those figures come from company and government sources, not a listed-company disclosure, so they should be read as indicative.

In July 2026, Galbot signed a cooperation agreement with Qiantang district in Hangzhou to build demonstration scenarios and a training base. Such partnerships provide real sites for testing, which is often more valuable to a robotics company than cash.

## The deeper question

Embodied intelligence (具身智能) has become the preferred term for systems that perceive, decide, and act in the physical world. The gap between a laboratory demonstration and a commercial robot is mostly a question of edge cases: the object nobody expected, the lighting that changed, the floor that is slightly slippery.

Galbot's bet is that a narrow task repeated thousands of times teaches more than a broad task performed once. Whether that approach generalises to new sites is the open question. A pharmacy in one city may not resemble a pharmacy in another, and each new customer adds integration work.

## Honest limitations

- The ¥2.5 billion round, the 24-city coverage, the 5,000-SKU figure, and the 50 kg payload are from Chinese media reporting company information. I found no independent audit.

- "Continuous operation for more than a year" is a company claim without published uptime or error-rate data.

- Customer relationships and order volumes are described in company releases; named manufacturers have not published confirmations in the sources reviewed.

- The reported valuation comes from local-government and media accounts, not a regulatory filing.

- Benchmark and capability claims about autonomous decision-making on stage were not accompanied by technical documentation.

## What readers can do now

- If you use an automated retail service, notice how it handles mistakes. Recovery behaviour tells you more about maturity than speed.

- For business buyers, ask for error rates and human-intervention frequency, not maximum payload or degrees of freedom.

- Treat funding announcements as a measure of investor confidence, not proof that the business model works at scale.

---

Published by NeuroAI (https://neuroai.site/) — https://neuroai.site/a/na-robot-galbot-pharmacy-funding
Free to quote with attribution and a link to the original.
